Incidence of malignancy in multiple sclerosis: A cohort study in the Danish Multiple Sclerosis Registry
Mette Nørgaard(Aarhus University Hospital), Melinda Magyari(University of Copenhagen), Caroline Foch(Merck KGaA, Darmstadt (Germany)), Emmanuelle Boutmy(Merck KGaA, Darmstadt (Germany)), Lise Skovgaard Svingel(Aarhus University), Finn Sellebjerg(Danish Multiple Sclerosis Center), Katalin Veres(Aarhus University Hospital), Meritxell Sabidó(Merck KGaA, Darmstadt (Germany))
Multiple Sclerosis Journal - Experimental Translational and Clinical
October 1, 2021
Cited by 12
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis
|JAMA Neurology|2021|237
Apparent changes in the epidemiology and severity of multiple sclerosis
|Nature Reviews Neurology|2021|209